RDGL — VIVOS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1449349 ·
Last close
$0.05
Market Cap
$22.69M
52W High
$0.12
52W Low
$0.04
ADV30
792,507
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 36,400 | -1,720 | -654,529 | -830,189 | 2,879,570 | 2,336,022 | 123,955 |
| Mar 2026 | 36,068 | -8,018 | -545,492 | -1,184,845 | 2,950,505 | 2,525,782 | 253,195 |
| Dec 2025 | 24,752 | -3,105 | -1,095,719 | -1,078,514 | 1,867,583 | 1,558,525 | 206,743 |
| Sep 2025 | 1,879 | -12,815 | -531,023 | -507,294 | 2,295,185 | 2,202,109 | 112,693 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,032,406
Investing CF
$-151,205
Financing CF
$1,547,478
CapEx
$-151,205
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-89,612,091
Inventory
$56,863
Receivables
$7,668
ST Investments
—
EBIT TTM
$-2,847,006
Pretax Income TTM
$-3,416,166
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$99,099
EBITDA
—
Free Cash Flow
$-1,544,673
Enterprise Value
$31,625,180
Total Cash
$2,336,022
Total Debt
$103,153
Shares Out
494,214,360
Trailing EPS
$-0.01
Book Value
$-0.01
ROE
-132.5%
ROA
-62.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 68,379 | -3,165,047 | -3,066,017 | 1,867,583 | 206,743 | 1,660,840 | -2,057,743 |
| Dec 2024 | 27,995 | -2,604,384 | -2,910,448 | 2,233,456 | 86,209 | 2,147,247 | -1,684,039 |
| Dec 2023 | 19,500 | -2,793,146 | -2,894,753 | 1,610,124 | 245,004 | 1,365,120 | -1,293,023 |
| Dec 2022 | 36,499 | -2,517,749 | -2,470,161 | 1,742,736 | 81,692 | 1,661,044 | -1,120,058 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GTHP | GUIDED THERAPEUTICS INC | $23.94M | $0.25 | — |
| BDMD | Baird Medical Investment Holdings Ltd | $24.53M | $0.77 | — |
| RVP | RETRACTABLE TECHNOLOGIES INC | $20.96M | $0.70 | — |
| FEMY | FEMASYS INC | $20.77M | $2.48 | — |
| BEAT | HeartBeam, Inc. | $20.29M | $0.36 | — |
News headlines (Yahoo Finance, 1h cache)
Vivos Inc. Peer-Reviewed PrecisionGel Publication Strengthens Scientific Case for Drug Delivery Platform
2026-09-03 13:59 · Yahoo
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
2026-08-28 12:45 · Yahoo
Vivos Begins IsoPet Shipments and Secures India Manufacturing Authorization
2026-08-18 14:47 · Yahoo
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufactur
2026-08-18 12:30 · Yahoo
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
2026-08-14 12:45 · Yahoo
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction
2026-07-27 14:49 · Yahoo
Vivos Reports FDA IDE Approval and Expands Precision Radionuclide Therapy Programs
2026-07-27 14:44 · Yahoo
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™
2026-07-06 12:30 · Yahoo
Vivos Receives Washington Radioactive Materials License for IsoPet Manufacturing, Enabling Domestic Production Expansion (RDGL)
2026-06-11 14:51 · Yahoo
Vivos Therapeutics Announces Material Debt Reduction
2026-09-08 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.